Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England

Author:

Perez-Guzman Pablo N.ORCID,Knock Edward,Imai NatsukoORCID,Rawson ThomasORCID,Elmaci Yasin,Alcada Joana,Whittles Lilith K.ORCID,Thekke Kanapram Divya,Sonabend Raphael,Gaythorpe Katy A. M.ORCID,Hinsley Wes,FitzJohn Richard G.,Volz ErikORCID,Verity RobertORCID,Ferguson Neil M.ORCID,Cori Anne,Baguelin MarcORCID

Abstract

AbstractAs the SARS-CoV-2 pandemic progressed, distinct variants emerged and dominated in England. These variants, Wildtype, Alpha, Delta, and Omicron were characterized by variations in transmissibility and severity. We used a robust mathematical model and Bayesian inference framework to analyse epidemiological surveillance data from England. We quantified the impact of non-pharmaceutical interventions (NPIs), therapeutics, and vaccination on virus transmission and severity. Each successive variant had a higher intrinsic transmissibility. Omicron (BA.1) had the highest basic reproduction number at 8.4 (95% credible interval (CrI) 7.8-9.1). Varying levels of NPIs were crucial in controlling virus transmission until population immunity accumulated. Immune escape properties of Omicron decreased effective levels of immunity in the population by a third. Furthermore, in contrast to previous studies, we found Alpha had the highest basic infection fatality ratio (3.0%, 95% CrI 2.8-3.2), followed by Delta (2.1%, 95% CrI 1.9–2.4), Wildtype (1.2%, 95% CrI 1.1–1.2), and Omicron (0.7%, 95% CrI 0.6-0.8). Our findings highlight the importance of continued surveillance. Long-term strategies for monitoring and maintaining effective immunity against SARS-CoV-2 are critical to inform the role of NPIs to effectively manage future variants with potentially higher intrinsic transmissibility and severe outcomes.

Funder

DH | National Institute for Health Research

Wellcome Trust

Department for International Development

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

Reference49 articles.

1. Office for National Statistics. International Comparisons of Possible Factors Affecting Excess Mortality. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/articles/internationalcomparisonsofpossiblefactorsaffectingexcessmortality/2022-12-20 (2022).

2. Sachs, J. D. et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet https://doi.org/10.1016/S0140-6736(22)01585-9 (2022).

3. Office for National Statistics. Early Insights into the Impacts of the Coronavirus (COVID-19) Pandemic and EU Exit on Business Supply Chains in the UK. https://www.ons.gov.uk/businessindustryandtrade/internationaltrade/articles/earlyinsightsintotheimpactsofthecoronaviruspandemicandeuexitonbusinesssupplychainsintheuk/february2021tofebruary2022 (2022).

4. Fan, Y. et al. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Sig Transduct. Target Ther. 7, 141 (2022).

5. Tan, S. T. et al. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave. Nat. Med. https://doi.org/10.1038/s41591-022-02138-x (2023).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3